FIDELIS CAPITAL PARTNERS, LLC

Position in JNJ — Johnson & Johnson

CIK 1962755 TAMPA, FL

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$14,154,763

+$2,967,722 QoQ

Shares Held

55,734

+21.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.13%

of 13F equity value

Holder Rank

#920

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 85% Shared 0% None 15%

Healthcare · as of Jun 30, 2026

FIDELIS CAPITAL PARTNERS, LLC holds $51,570,809 across 10 Drug Manufacturers - General names. JNJ ranks #1 (27.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	55,734	$14,154,763
2	LLY	ELI LILLY & Co	11,461	$13,746,668
3	ABBV	AbbVie Inc.	38,686	$9,734,945
4	MRK	Merck & Co., Inc.	51,693	$6,642,550
5	AMGN	Amgen Inc	8,119	$2,940,052
6	BMY	Bristol Myers Squibb Co	27,994	$1,613,014
7	PFE	Pfizer Inc	51,883	$1,249,342
8	GILD	Gilead Sciences, Inc.	6,859	$866,566

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,154,763	55,734	+21.8%	Shares	Sole	2026-08-13
2026-03-31	$11,187,041	45,766	+1.7%	Shares	Sole	2026-05-06
2025-12-31	$9,310,059	44,987	+20.5%	Shares	Sole	2026-02-09
2025-09-30	$6,924,695	37,346	+14.1%	Shares	Sole	2025-11-03
2025-06-30	$4,999,660	32,731	+0.4%	Shares	Sole	2025-08-07
2025-03-31	$5,407,876	32,609	+8.8%	Shares	Sole	2025-05-01
2024-12-31	$4,334,695	29,973	+4.2%	Shares	Sole	2025-02-06
2024-09-30	$4,660,845	28,760	+8.1%	Shares	Sole	2024-10-25
2024-06-30	$3,888,586	26,605	+10.2%	Shares	Sole	2024-08-13
2024-03-31	$3,819,497	24,145	+40.3%	Shares	Sole	2024-05-06
2023-12-31	$2,697,025	17,207	+30.5%	Shares	Sole	2024-01-31
2023-09-30	$2,052,940	13,181	+17.8%	Shares	Sole	2023-11-08
2023-06-30	$1,852,003	11,189	+3.4%	Shares	Sole	2023-08-10
2023-03-31	$1,677,100	10,820	+145.5%	Shares	Sole	2023-05-09
2022-12-31	$778,496	4,407	—	Shares	Sole	2023-01-20
No filing history on record for this holder in this stock.